AYTU
Aytu BioScience Inc
NASDAQ: AYTU · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.58
+2.38% today
Updated 2026-04-30
Market cap
$27.05M
P/E ratio
—
P/S ratio
0.43x
EPS (TTM)
$-3.44
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Aytu BioScience Inc (AYTU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-39.00%
Operating margin
-13.00%
ROE
-109.20%
ROA
-0.22%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | — | $-48954.00 | — | — | — |
| 2008 | — | $-57173.00 | — | — | — |
| 2009 | $1750.00 | $-58894.00 | 100.00% | -3,189.83% | -3,365.37% |
| 2010 | — | $-60270.00 | — | — | — |
| 2011 | — | $-136802.00 | — | — | — |
| 2012 | $1750.00 | $-59675.00 | 100.00% | -3,220.34% | -3,410.00% |
| 2013 | $1750.00 | $-57318.00 | 2,857.14% | -2,995.09% | -3,275.31% |
| 2014 | $58929.00 | $-5.58M | 100.00% | -10,770.31% | -9,466.80% |
| 2015 | $261782.00 | $-7.72M | 66.34% | -2,915.53% | -2,950.32% |
| 2016 | $2.56M | $-28.18M | 62.65% | -847.02% | -1,099.73% |
| 2017 | $3.22M | $-22.51M | 56.00% | -624.70% | -698.67% |
| 2018 | $3.66M | $-10.19M | 43.97% | -538.26% | -278.36% |
| 2019 | $7.32M | $-47.17M | 69.92% | -230.13% | -644.33% |
| 2020 | $27.63M | $-13.62M | 70.03% | -76.47% | -49.29% |
| 2021 | $65.63M | $-58.29M | 44.49% | -89.70% | -88.81% |
| 2022 | $96.67M | $-108.78M | 52.02% | -113.69% | -112.53% |
| 2023 | $107.40M | $-17.05M | 62.04% | -15.89% | -15.88% |
| 2024 | $65.18M | $-15.84M | 75.26% | -2.44% | -24.31% |
| 2025 | $66.38M | $-13.56M | 69.04% | -11.79% | -20.43% |